United Kingdom · Question · Written question
UIN 47663
Respiratory Syncytial Virus: Vaccination
Original
Introduced
5 September 2022
Last action
20 September 2022 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
20 September 2022
Summary
To ask the Secretary of State for Health and Social Care, with reference to recommendations in the consensus statement of the 2017 International Conference on the Standards of Care on the use of Palivizumab for some categories of children with spinal musc
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
5 September 2022
Written question
To ask the Secretary of State for Health and Social Care, with reference to recommendations in the consensus statement of the 2017 International Conference on the Standards of Care on the use of Palivizumab for some categories of children with spinal musc
Source: Commons
20 September 2022
Answer
Respiratory syncytial virus (RSV) infection poses a serious risk for children with spinal muscular atrophy (SMA) with weakened respiratory muscles due to their condition. Following a letter from clinicians, the Joint Committee on Vaccination and Immunisat...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2022-09-05/47663
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1504892
- uk · wq-1504892 · source updated 20 September 2022